Terms: = Lung cancer AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43
77 results:
1. Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1-ndrg1 deregulation.
Mayayo-Peralta I; Debets DO; Prekovic S; Schuurman K; Beerthuijzen S; Almekinders M; Sanders J; Moelans CB; Saleiro S; Wesseling J; van Diest PJ; Henrique R; Jerónimo C; Altelaar M; Zwart W
Mol Oncol; 2024 Jan; 18(1):156-169. PubMed ID: 37854018
[TBL] [Abstract] [Full Text] [Related]
2. Roles of hypoxic environment and M2 macrophage-derived extracellular vesicles on the progression of non-small cell lung cancer.
Chu X; Wang Z; Wang W; Liu W; Cao Y; Feng L
BMC Pulm Med; 2023 Jul; 23(1):239. PubMed ID: 37400770
[TBL] [Abstract] [Full Text] [Related]
3. The GR-SGK1-ndrg1 Pathway as a Predictor of Recurrence and Prognosis in lung Adenocarcinoma After Radical Surgery.
Sasaki T; Nakamura Y; Hata S; Shimada H
Anticancer Res; 2023 Jul; 43(7):2965-2974. PubMed ID: 37351994
[TBL] [Abstract] [Full Text] [Related]
4. A review on the role of ndrg1 in different cancers.
Ghafouri-Fard S; Ahmadi Teshnizi S; Hussen BM; Taheri M; Sharifi G
Mol Biol Rep; 2023 Jul; 50(7):6251-6264. PubMed ID: 37249826
[TBL] [Abstract] [Full Text] [Related]
5. ndr1 activates CD47 transcription by increasing protein stability and nuclear location of ASCL1 to enhance cancer stem cell properties and evasion of phagocytosis in small cell lung cancer.
Wang LL; Wan XY; Wang TL; Liu CQ; Zheng FM
Med Oncol; 2022 Oct; 39(12):254. PubMed ID: 36224405
[TBL] [Abstract] [Full Text] [Related]
6. Proteomic and Phosphoproteomic Analyses Reveal the Oncogenic Role of PTK7-ndrg1 Axis in Non-small-cell lung cancer Cell Resistance to AZD9291.
Wang Z; Lei P; Li Z; Han X; Yang F; Su T; Meng C; Hou Z; Liu H
ACS Chem Biol; 2022 Oct; 17(10):2849-2862. PubMed ID: 36205702
[TBL] [Abstract] [Full Text] [Related]
7. The Ni(II)-Binding Activity of the Intrinsically Disordered Region of Human ndrg1, a Protein Involved in cancer Development.
Beniamino Y; Cenni V; Piccioli M; Ciurli S; Zambelli B
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139110
[TBL] [Abstract] [Full Text] [Related]
8. Monte Carlo modeling of the Elekta Versa HD and patient dose calculation with EGSnrc/BEAMnrc.
Paschal HMP; Kabat CN; Papaconstadopoulos P; Kirby NA; Myers PA; Wagner TD; Stathakis S
J Appl Clin Med Phys; 2022 Sep; 23(9):e13715. PubMed ID: 35985698
[TBL] [Abstract] [Full Text] [Related]
9. Planning evaluation of a novel volume-based algorithm for personalized optimization of lung dose in VMAT for esophageal cancer.
Hsu CX; Lin KH; Wang SY; Tsai WT; Chang CH; Tien HJ; Shueng PW; Wu TH; Mok GSP
Sci Rep; 2022 Feb; 12(1):2513. PubMed ID: 35169144
[TBL] [Abstract] [Full Text] [Related]
10. Boosting Room Temperature Phosphorescence Performance by Alkyl Modification for Intravital Orthotopic lung Tumor Imaging.
Gao H; Gao Z; Jiao D; Zhang J; Li X; Tang Q; Shi Y; Ding D
Small; 2021 Jun; 17(22):e2005449. PubMed ID: 33599120
[TBL] [Abstract] [Full Text] [Related]
11. Inhalation Toxicity of Talc.
Johnson NF
J Aerosol Med Pulm Drug Deliv; 2021 Apr; 34(2):79-107. PubMed ID: 32816595
[TBL] [Abstract] [Full Text] [Related]
12. Linc00173 promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression.
Zeng F; Wang Q; Wang S; Liang S; Huang W; Guo Y; Peng J; Li M; Zhu W; Guo L
Oncogene; 2020 Jan; 39(2):293-307. PubMed ID: 31477834
[TBL] [Abstract] [Full Text] [Related]
13. UTE-mDixon-based thorax synthetic CT generation.
Su KH; Friel HT; Kuo JW; Al Helo R; Baydoun A; Stehning C; Crisan AN; Traughber MS; Devaraj A; Jordan DW; Qian P; Leisser A; Ellis RJ; Herrmann KA; Avril N; Traughber BJ; Muzic RF
Med Phys; 2019 Aug; 46(8):3520-3531. PubMed ID: 31063248
[TBL] [Abstract] [Full Text] [Related]
14. NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells.
Keller M; Dubois F; Teulier S; Martin APJ; Levallet J; Maille E; Brosseau S; Elie N; Hergovich A; Bergot E; Camonis J; Zalcman G; Levallet G
J Exp Clin Cancer Res; 2019 Apr; 38(1):158. PubMed ID: 30979377
[TBL] [Abstract] [Full Text] [Related]
15. ndrg1 Downregulates ATF3 and Inhibits Cisplatin-Induced Cytotoxicity in lung cancer A549 Cells.
Du A; Jiang Y; Fan C
Int J Med Sci; 2018; 15(13):1502-1507. PubMed ID: 30443171
[TBL] [Abstract] [Full Text] [Related]
16. MORC2 promotes development of an aggressive colorectal cancer phenotype through inhibition of ndrg1.
Liu J; Shao Y; He Y; Ning K; Cui X; Liu F; Wang Z; Li F
Cancer Sci; 2019 Jan; 110(1):135-146. PubMed ID: 30407715
[TBL] [Abstract] [Full Text] [Related]
17. Emerging roles of ADP-ribosyl-acceptor hydrolases (ARHs) in tumorigenesis and cell death pathways.
Bu X; Kato J; Moss J
Biochem Pharmacol; 2019 Sep; 167():44-49. PubMed ID: 30267646
[TBL] [Abstract] [Full Text] [Related]
18. Targeting of SGK1 by miR-576-3p Inhibits lung Adenocarcinoma Migration and Invasion.
Greenawalt EJ; Edmonds MD; Jain N; Adams CM; Mitra R; Eischen CM
Mol Cancer Res; 2019 Jan; 17(1):289-298. PubMed ID: 30257988
[TBL] [Abstract] [Full Text] [Related]
19. mTORC2 contributes to the metabolic reprogramming in EGFR tyrosine-kinase inhibitor resistant cells in non-small cell lung cancer.
Chiang CT; Demetriou AN; Ung N; Choudhury N; Ghaffarian K; Ruderman DL; Mumenthaler SM
Cancer Lett; 2018 Oct; 434():152-159. PubMed ID: 30036610
[TBL] [Abstract] [Full Text] [Related]
20. ndrg1 disruption alleviates cisplatin/sodium glycididazole-induced DNA damage response and apoptosis in ERCC1-defective lung cancer cells.
He L; Liu K; Wang X; Chen H; Zhou J; Wu X; Liu T; Yang Y; Yang X; Cui D; Song G; Wang J; Lei J
Int J Biochem Cell Biol; 2018 Jul; 100():54-60. PubMed ID: 29768183
[TBL] [Abstract] [Full Text] [Related]
[Next]
